Open Access in
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.
Open Access Fees
Research Papers and Reports, OA fee is $750.00 USD
Reviews, Brief Reports and Short Communications, OA fee is $500.00 USD
All other types of papers, OA fee is $250.00
Submit your paper to Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics (HV&I) utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.
Click here to submit your manuscript to HV&I.
HV&I is indexed in Medline/PubMed and in the Science Citation Index Expanded.
Superbugs & Superdrugs
March 4-5, 2013
3rd Annual Vaccine World Summit
March 5-7, 2013
Host Response in Tuberculosis &
Tuberculosis: Understanding the Enemy- Keystone Symposia
Mar. 13-18, 2013
Whistler, BC CA
Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications- Keystone Symposium
April 3-8, 2013
Breckenridge, CO USA
World Vaccine Congress & Expo USA
April 16-18, 2013
The Innate Immune Response in the Pathogenesis of Infectious Disease- Keystone Symposium
May 10-15, 2013
Ouro Preto, Brazil
World Vaccine Congress & Expo Europe
October 16-17, 2013